Selected Clinical Calculations Chapter 10. Heparin-Dosing calculations

Similar documents
TDM of Aminoglycoside Antibiotics

Career Corner: Pharmaceutical Calculations for Technicians. Ashlee Mattingly, PharmD, BCPS

PHARMACOKINETICS SMALL GROUP II:

TDM Lecture 7 5 th Stage. TDM of Digoxin. Uses: Digoxin is usually used in heart failure associated and atrial fibrillation.

PHA5128 Dose Optimization II Case Study 3 Spring 2013

Use ideal body weight (IBW) unless actual body weight is less. Use the following equation to calculate IBW:

IV Vancomycin dosing and monitoring Antibiotic Guidelines. Contents. Intro

Full title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control

Electrolytes Solution

DEEP VEIN THROMBOSIS (DVT): TREATMENT

INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS

Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University

. Although there is a little

Gemcitabine + Cisplatin Regimen

Name: UFID: PHA Exam 2. Spring 2013

PHA Spring First Exam. 8 Aminoglycosides (5 points)

Using Dynamed (iphone Version) FSU College of Medicine

Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy

Case Study 2 Answers Spring 2006

ISSUES OF THE OBESE DOSING. Janine Then, PharmD, BCPS

Drug dosing in Extremes of Weight

Policy: Created: 2/11/2015; Approved: Adult Pharmacokinetic Dosing and Monitoring- Vancomycin Dosing

These are guidelines only and can be deviated from if it is thought to be in the patient s best interest.

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

StRs and CT doctors in haematology. September Folinic acid dose modified.

TDM of Digoxin. Use of Digoxin Serum Concentrations to Alter Dosages

Counties in the top and bottom two quintiles of both diabetes and obesity, Age-adjusted percentage of adults aged 20 years who are obese, 2007

Review calculation procedures for the following:

Medication Calculation Practice Problems

Module 8: Practice Problems

ADULT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) TELEMETRY BED TRANSFER ORDERS 1 of 4

Renal Function and Associated Laboratory Tests

PHA5128 Dose Optimization II Case Study I Spring 2013

Bevacizumab + Paclitaxel + Cisplatin

WMC PHARMACY ANTICOAGULATION PROTOCOL Current Revision: July 2017 GENERAL ORDER PROCESSING AND MANAGEMENT

Jessica Bryan, Natalia Evans, Karlyn Henderson, & Whitney Parks

Venothromboembolism prophylaxis: Trauma and Orthopaedics Clinical guideline, V2

Admit date (YYYY/MM/DD): Cardiologist On-Call: Diagnosis: Lab Tests. CBC, Electrolytes, Urea, Creatinine, Glucose, INR, PTT, Urinalysis

PHA Case Studies V (Answers)

Bevacizumab + Paclitaxel & Carboplatin

NORMOSOL -R MULTIPLE ELECTROLYTES INJECTION TYPE 1, USP For Replacing Acute Losses of Extracellular Fluid Flexible Plastic Container

AMINOGLYCOSIDES TDM D O N E B Y

Acute Stroke with Alteplase Administration Order Set

Nonparenteral medications

Incorporated Dosing Guidelines: Intravenous Heparin Therapy Initial Dose

Module 8: Electrolyte Solutions

Name Date Period. West Nomogram

SHC Vancomycin Dosing Guide

Cisplatin Doxorubicin Sarcoma

WEEK. MPharm Programme. Acute Kidney Injury. Alan M. Green MPHM13: Acute Kidney Injury. Slide 1 of 47

1 Acute Lymphoblastic Leukaemia

Adult Institutional Pharmacokinetics Protocol

Morbid Obesity: Multi system Considerations for Acute Care

Chemistry Reference Ranges and Critical Values

Filtration and Reabsorption Amount Filter/d

Chemistry Reference Ranges and Critical Values

PRESCRIBING IN LIVER AND RENAL DISEASE

General, Organic & Biological Chemistry, 5e (Timberlake) Chapter 2 Chemistry and Measurements. 2.1 Multiple-Choice Questions

P-RMS: LT/H/PSUR/0004/001

PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT

Adjusting phenytoin dosage in complex patients: how to win friends and influence patient outcomes

DBL MAGNESIUM SULFATE CONCENTRATED INJECTION

Cisplatin and Gemcitabine Bladder Cancer: Full and split dose

PRODUCT MONOGRAPH. Pr innohep. tinzaparin sodium. Sterile solution for SC injection. Multi-dose vial 10,000 anti-xa IU/mL 20,000 anti-xa IU/mL

CRRT Fundamentals Pre-Test. AKI & CRRT 2017 Practice Based Learning in CRRT

SLCC Math 1020 Fall 2010 Final Exam Name: Part I: You are not allowed to use calculators, books, or notes. Answer all questions. Do it by yourself.

Assessing Renal Function: What you Didn t Know You Didn t Know

Title: Low Molecular Weight Heparins (LMWH), fondaparinux (Arixtra)

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults

Renal function vs chemotherapy dosing

Clinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date:

Basic Fluid and Electrolytes

Glomerular Filtration Rate. Hui Li, PhD, FCACB, DABCC

Disclosures. Overview. Have you ever. The Perioperative Management of Anticoagulants. No financial conflicts of interest to disclose

Blood products and plasma substitutes

Venous Thromboembolism Prophylaxis

TCHP Docetaxel, Carboplatin, Trastuzumab, Pertuzumab Neoadjuvant Protocol

(telavancin) Healthcare Professional s Guide. Version 2, 4 November 2014

Foo Koon Mian Pharmacy Resident National University of Singapore Hematology / Oncology Pharmacy Residency Program. 4th APOPC November 2012

TIP Paclitaxel, Ifosfamide and Cisplatin

DOSAGE AND ADMINISTRATION

5-FU & Cisplatin + Cetuximab

R-IDARAM. Dexamethasone is administered as an IV infusion in 100mL sodium chloride 0.9% over 30 minutes.

ST. DOMINIC-JACKSON MEMORIAL HOSPITAL JACKSON, MISSISSIPPI. CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) HEPARIN ANTICOAGULATION Page 1 of 5

DIAGNOSIS AND MANAGEMENT OF DIURETIC RESISTANCE. Jules B. Puschett, M.D.

Capecitabine + Concurrent Radiotherapy

Lab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure.

THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST. Systemic Anti Cancer Treatment Protocol. EDP + mitotane

RENAL SYSTEM 2 TRANSPORT PROPERTIES OF NEPHRON SEGMENTS Emma Jakoi, Ph.D.

INTRAVENOUS FLUIDS PRINCIPLES

PRODUCT MONOGRAPH. innohep. tinzaparin sodium. Sterile solution for SC injection. Multi-dose vial 10,000 anti-xa IU/mL 20,000 anti-xa IU/mL

Carboplatin / Liposomal Doxorubicin CARBO/CAELYX Gynaecological Cancer

ECN Protocol Book. Generic Chemotherapy Protocol Guidelines. ECN_Protocol_Book_generic chemotherapy protocol guidelines guidelines_1

= (6000 ml air / min * 0.04 ml CO 2 / ml air) / 54 ml CO 2 / dl plasma

50% Concentrated Injection

Metformin Associated Lactic Acidosis. Jun-Ki Park 9/6/11

Doses Target Concentration Intervention

Lecture-2 Review of the previous lecture:

Cisplatin Vinorelbine (Oral) therapy +/- radiotherapy

Normosol -R and 5% Dextrose Injection MULTIPLE ELECTROLYTES AND 5% DEXTROSE INJECTION TYPE 1, USP For Replacing Acute Losses of Extracellular Fluid

Transcription:

Selected Clinical Calculations Chapter 10 Heparin-Dosing calculations Heparin is a heterogeneous group of muco-polysaccharides that have anticoagulant properties (slows clotting time). Heparin salt, as heparin sodium, are standardized to contain 140 USP heparin Units in each milligram. Heparin salts administered as sterile aqueous solutions by intravenous infusion, intermittent intravenous injection, or deep subcutaneous injection for the prophylaxis and treatment of venous thrombosis. 1

Heparin-Dosing calculations Dosage of Heparin sodium is adjusted according to the level of blood coagulation or partial thromboplastin time (PTT) Doses from 5000 Units up to 120,000 Units (patients with massive pulmonary emboli). In pediatric use, initial dose 50 mg/kg by IV drip, followed by maintenance doses of 100 mg/kg every 4 hours or 20,000 units/m 2 /24 hours. A variety of low-molecular-weight heparins (fragments of heparins) are also used as antithrombotic agents e.g. enoxaprin sodium (Lovenox) and dalteparin sodium (FRAGMIN). Heparin-Dosing calculations Example: An intravenous infusion contained 20,000 units of heparin sodium in 1000 ml of D5W. The rate of infusion was set at 1600 units per hour for a 160- lb patient. Calculate a) the concentration of heparin sodium in the infusion, in units/ml b) the length of time the infusion would run, in hours c) the dose of heparin sodium administered to the patient, on units/kg/minute basis. a) 20,000 units 1000 ml 200001 X units 1 ml X = 20 units/ml 1000 b) 1600 units 1 hour 200001 20,000 units X hour X = 12.5 hours 1600 c) 160 /2.2 = 72.7 kg AND 12.5 hour = 750 minutes 20,000 units 750 minutes 200001 X units 1 minute X = 26.67 units/minute 750 26.67 units 72.7 kg 26.671 X units 1 kg X = 0.37 units/kg/minute 72.7 2

Low-Molecular-Weight Heparin-Dosing calculations Example: The recommended dose of dalteparin sodium (FRAGMIN) for patients undergoing hip replacement surgery is 2500 international units (IU) within 2 hours before surgery, 2500 IU 4 to 8 hours after surgery, and 5000 IU daily X 5 to 10 days, starting on the postoperative day. How many millilitres from a vial containing 10,000 IU/ml should be administered a) before surgery b) After surgery c) The day following the surgery a) 10,000 units 1 ml 25001 2500 units X ml SO X = 0.25 ml 10000 b) same as a) = 0.25 ml c) 10,000 units 1 ml 50001 5000 units X ml SO X = 0.5 ml 10000 Example Calculations of Ideal Body Weight To maintain a specific drug concentration in the blood for proper therapeutic effect. Dose of drug depends, in part, on the weight of the patient and the volume of body fluids which the drug is distributed. It is important for estimation of Vd particularly for some polar drugs that are not well distributed in adipose tissue. Ideal body weight (IBW) is calculated as follows: For males : IBW = 50 kg + 2.3 kg for each inch of patient height over 5 feet IBW = 110 lb + 5 lb for each inch over 5 feet For females: IBW = 45.5kg + 2.3 kg for each inch of patient height over 5 feet IBW = 100 lb + 5 lb for each inch over 5 feet 3

Example Calculations of Ideal Body Weight Calculate the ideal body weight for a male patient weighing 164 lb, and measuring 5 ft. 8 in. in height. IBW = 110 lb + (8 x 5 lb.) = 110 lb. + 40 lb. = 150 lb., answer. Calculate the ideal body weight for a female patient weighing 60 kg and measuring 160 cm in height. 160 cm = 63 in. = 5 ft. 3 in. IBW = 45.5kg + (3 x 2.3 kg) = 45.5 kg + 6.9 kg = 52.4 kg, answer. Drugs are eliminated from the body through two major mechanisms Hepatic (liver) metabolism and Renal (kidney) excretion. Polar drugs are eliminated predominantly by renal excretion. The kidneys receives about 20% of the cardiac output and filter approximately 125 ml per minute of plasma. If the function is lost drug clearance will decrease. The filtration rate of the kidney can be estimated by a number of methods. One of the most useful, is the estimation of the creatinine clearance rate (CrCl) through the use of empiric formulas. Creatinine is break-down product of muscle metabolism, produced in a constant rate depends on the muscle mass and eliminated by renal filtration (kidney). The normal adult value of serum creatinine is 0.7-1.5 mg/dl 4

Creatinine clearance rate (CrCl, ml/min): Is the volume of blood plasma that is cleared of creatinine by kidney filtration per minute. Calculated by 1- Jellife equation: 98 0.8patient ' s age in years 20 For males: CrCl serum creatinine in mg / dl For females: CrCl = 0.9 X CrCl determined using formula for males 2- Cockcroft-Gault equation 140 patient ' s age in years Body weight in kg For males: CrCl 72 serum creatinine in mg / dl For females: CrCl = 0.85 X CrCl determined using formula for males 3- Sanaka equation (for patients over 60 years of age): For males: patient ' s weight kg19 Plasma albumin g / dl CrCl 100 serum creatinine mg / dl 32 For females: CrCl patient ' s weight 100 kg13 Plasma albumin g / dl serum creatinine mg / dl 29 4- Schwartz equation (for pediatric and adolescent patients from neonates to 17 years of age): k patient ' s height cm CrCl serum creatinine mg / dl K is proportionality constant ranging from 0.33 (for neonates) to 0.7 (for adolescent males) 5

Adjusting creatinine clearance for body surface area: Is accomplished through the use of a nomogram of body surface area (BSA), as described previously in Chapter 8, and the following formula: 2 BSA ( m ) CrCl Adjusted CrCl 1.73 Example: If a patient weighing 120 lb. and measuring 60 in. in height has a calculated creatinine clearance of 40 ml per minute, adjust the CrCl based on body surface area? Using the nomogram in Ch. 8, the patient s BSA is determined to be 1.5 m 2 Adjusted CrCl = (1.5/1.73) X 40 = 34.7 ml/min Example: Determine the creatinine clearance rate for an 80-year-old male patient weighing 70 kg and having a serum creatinine of 2 mg/dl. Use both the jelliffe and Cockcroft-Gault equations. 1- Jellife equation: 2- Cockcroft-Gault equation 140 patient ' s age in years Body weight in kg CrCl 72 serum creatinine in mg / dl 98 0.8 patient ' s age in years 20 CrCl serum creatinine in mg / dl 98 0.8 80 20 98 (0.8 60) 98 48 CrCl 25 ml 2 ( mg / dl) 2 2 min 140 80 70 6070 CrCl 29.2 ml 72 2 ( mg / dl) 144 min 6

Calculations Involving Clinical Laboratory Tests Clinical laboratory tests (chemistries) analyze samples for chemicals as, glucose, cholesterol, total lipids, creatinine, bilirubin, sodium, potassium, carbon dioxide and other substances, including drugs following their administration. The usual amount of a chemical substance is a common range, e.g. glucose in serum is 65-99 mg/dl and for creatinine is 0.5-1.4 mg/dl Units may change from mg/dl to SI units of millimoles per liter (mmol/l) of blood plasma Example: If a patient is determined to have a serum cholesterol level of 200 mg/dl, what is the equivalent value expressed in terms of mmol/l. M.W. of cholesterol = 387 1 mmol = 387 mg and 200 mg/dl= 2000 mg/l 387 mg 1 mmol 2000 mg X mmol X = 5.17 mmol/l Practice Problems Page 163: 1 and 3. Page 164: 5, 7, 9, 11, 13, 15, 17. Page 165: 19. 7